Found: 52
Select item for more details and to access through your institution.
Expression of Metabolic Syndrome in Women with Severe Obesity.
- Published in:
- Metabolic Syndrome & Related Disorders, 2017, v. 15, n. 6, p. 283, doi. 10.1089/met.2016.0116
- By:
- Publication type:
- Article
Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Estrogen Receptor 1 Variants and Coronary Artery Disease: Shedding Light Into a Murky Pool.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 17, p. 2317, doi. 10.1001/jama.290.17.2317
- By:
- Publication type:
- Article
Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2000, v. 284, n. 10, p. 1263, doi. 10.1001/jama.284.10.1263
- By:
- Publication type:
- Article
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Waist‐hip ratio as a moderator of the effects of hormone therapy on cognitive function in recently menopausal women.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056539
- By:
- Publication type:
- Article
Metabolic Determinants of Low HDL-C Levels.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 676, n. 1, p. 157, doi. 10.1111/j.1749-6632.1993.tb38731.x
- By:
- Publication type:
- Article
Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 11, p. 1004, doi. 10.1111/j.1463-1326.2008.00903.x
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- Vascular Health & Risk Management, 2015, v. 11, p. 165, doi. 10.2147/VHRM.S70907
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
- Published in:
- 2015
- By:
- Publication type:
- journal article
P4-402: Baseline cognitive and demographic characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)
- Published in:
- 2008
- By:
- Publication type:
- Abstract
A new phenotypic classification system for dyslipidemias based on the standard lipid panel.
- Published in:
- Lipids in Health & Disease, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12944-021-01585-8
- By:
- Publication type:
- Article
Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2000, v. 107, n. 8, p. 1017, doi. 10.1111/j.1471-0528.2000.tb10406.x
- By:
- Publication type:
- Article
Characterization of Vascular Disease Risk in Postmenopausal Women and Its Association with Cognitive Performance.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068741
- By:
- Publication type:
- Article
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
- Published in:
- European Heart Journal, 2024, v. 45, n. 13, p. 1173, doi. 10.1093/eurheartj/ehad889
- By:
- Publication type:
- Article
Hyperlipoproteinemia Type 3: The Forgotten Phenotype.
- Published in:
- Current Atherosclerosis Reports, 2014, v. 16, n. 9, p. 1, doi. 10.1007/s11883-014-0440-2
- By:
- Publication type:
- Article
Effects of Ethanol Intake on Lipoproteins.
- Published in:
- Current Atherosclerosis Reports, 2012, v. 14, n. 2, p. 108, doi. 10.1007/s11883-012-0230-7
- By:
- Publication type:
- Article
Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio?
- Published in:
- Current Atherosclerosis Reports, 2008, v. 10, n. 1, p. 25, doi. 10.1007/s11883-008-0005-3
- By:
- Publication type:
- Article
Clinical trials report.
- Published in:
- Current Atherosclerosis Reports, 2002, v. 4, n. 5, p. 402, doi. 10.1007/s11883-002-0079-2
- By:
- Publication type:
- Article
Controversies in Dyslipidemias: Atheroprevention in Diabetes and Insulin Resistance.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1055, n. 1, p. 159, doi. 10.1196/annals.1323.024
- By:
- Publication type:
- Article
Is the Estrogen Controversy Over?: Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1052, n. 1, p. 43, doi. 10.1196/annals.1347.004
- By:
- Publication type:
- Article
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2148172, doi. 10.1001/jamanetworkopen.2021.48172
- By:
- Publication type:
- Article
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-100
- By:
- Publication type:
- Article
The role of fibric acid derivatives in the secondary prevention of coronary heart disease.
- Published in:
- Current Cardiology Reports, 2000, v. 2, n. 5, p. 452, doi. 10.1007/s11886-000-0060-z
- By:
- Publication type:
- Article
Effects of Angiotensin II Type 1 Receptor Blockade on ß-Cell Function in Humans.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Amputation Prevention by Vascular Surgery and Podiatry Collaboration in High-Risk Diabetic and Nondiabetic Patients.
- Published in:
- Diabetes Care, 1999, v. 22, n. 5, p. 678, doi. 10.2337/diacare.22.5.678
- By:
- Publication type:
- Article
An <i>In-Silico</i> Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway.
- Published in:
- PLoS Computational Biology, 2014, v. 10, n. 3, p. 1, doi. 10.1371/journal.pcbi.1003509
- By:
- Publication type:
- Article
Understanding Patient Adherence and Concerns with STatins and MedicatION Discussions With Physicians (ACTION): A survey on the patient perspective of dialogue with healthcare providers regarding statin therapy.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 6, p. 710, doi. 10.1002/clc.22975
- By:
- Publication type:
- Article
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
- Published in:
- Clinical Cardiology, 2017, v. 40, n. 3, p. 138, doi. 10.1002/clc.22692
- By:
- Publication type:
- Article
Newer HMG-CoA reductase inhibitor (statin) therapies.
- Published in:
- Clinical Cardiology, 2001, v. 24, n. S2, p. 10, doi. 10.1002/clc.4960240705
- By:
- Publication type:
- Article
Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events.
- Published in:
- American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 179, doi. 10.2165/11592560-000000000-00000
- By:
- Publication type:
- Article
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 1, p. 1, doi. 10.1161/JAHA.123.032413
- By:
- Publication type:
- Article
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 5, p. 1, doi. 10.1161/JAHA.121.026756
- By:
- Publication type:
- Article
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.
- Published in:
- CardioRenal Medicine, 2019, v. 9, n. 4, p. 240, doi. 10.1159/000499341
- By:
- Publication type:
- Article
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA).
- Published in:
- Lipids in Health & Disease, 2017, v. 16, p. 1, doi. 10.1186/s12944-017-0415-8
- By:
- Publication type:
- Article
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
- Published in:
- Lipids in Health & Disease, 2016, v. 15, p. 1, doi. 10.1186/s12944-016-0282-8
- By:
- Publication type:
- Article
Lipids, Safety Parameters, and Drug Concentrations After an Additional 2 Years of Treatment With Anacetrapib in the DEFINE Study.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2014, v. 19, n. 6, p. 543, doi. 10.1177/1074248414529621
- By:
- Publication type:
- Article
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.
- Published in:
- European Heart Journal Open, 2023, v. 3, n. 6, p. 1, doi. 10.1093/ehjopen/oead114
- By:
- Publication type:
- Article
Arterial Imaging Outcomes and Cardiovascular Risk Factors in Recently Menopausal Women.
- Published in:
- Annals of Internal Medicine, 2014, v. 161, n. 4, p. 249, doi. 10.7326/M14-0353
- By:
- Publication type:
- Article
Menopausal Hormone Therapy and Risk for Cardiovascular Disease in the WHI Trial.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Management of hypercholesterolemia for prevention of atherosclerotic cardiovascular disease: focus on the potential role of recombinant anti-PCSK9 monoclonal antibodies.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Management of Hypercholesterolemia for Prevention of Atherosclerotic Cardiovascular Disease: Focus on the Potential Role of Recombinant Anti-PCSK9 Monoclonal Antibodies.
- Published in:
- Reviews in Cardiovascular Medicine, 2014, v. 15, n. 2, p. 86, doi. 10.3909/ricm0741
- By:
- Publication type:
- Article
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study.
- Published in:
- PLoS Medicine, 2015, v. 12, n. 6, p. 1, doi. 10.1371/journal.pmed.1001833
- By:
- Publication type:
- Article
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.
- Published in:
- Journal of Women's Health (15409996), 2018, v. 27, n. 9, p. 1170, doi. 10.1089/jwh.2017.6757
- By:
- Publication type:
- Article
Ectopic fat and adipokines in metabolically benign overweight/obese women: The kronos early estrogen prevention study.
- Published in:
- Obesity (19307381), 2013, v. 21, n. 8, p. 1726, doi. 10.1002/oby.20200
- By:
- Publication type:
- Article
Health Outcomes of Gastric Bypass Patients Compared to Nonsurgical, Nonintervened Severely Obese.
- Published in:
- Obesity (19307381), 2010, v. 18, n. 1, p. 121, doi. 10.1038/oby.2009.178
- By:
- Publication type:
- Article
Lipid abnormalities in the metabolic syndrome.
- Published in:
- Current Diabetes Reports, 2003, v. 3, n. 1, p. 65, doi. 10.1007/s11892-003-0056-3
- By:
- Publication type:
- Article